A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.

BACKGROUND: Pancreatitis-associated protein (PAP) is a pancreatic secretory protein belongs to the group VII of C-type lectin family. Emerging evidence suggests that PAP plays a protective effect in inflammatory diseases. In the present study, we newly identified a 16-amino-acid peptide (named PAPep...

Full description

Bibliographic Details
Main Authors: Xiaolu Yang, Huiyi Jin, Kun Liu, Qing Gu, Xun Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3237597?pdf=render
_version_ 1819043245758349312
author Xiaolu Yang
Huiyi Jin
Kun Liu
Qing Gu
Xun Xu
author_facet Xiaolu Yang
Huiyi Jin
Kun Liu
Qing Gu
Xun Xu
author_sort Xiaolu Yang
collection DOAJ
description BACKGROUND: Pancreatitis-associated protein (PAP) is a pancreatic secretory protein belongs to the group VII of C-type lectin family. Emerging evidence suggests that PAP plays a protective effect in inflammatory diseases. In the present study, we newly identified a 16-amino-acid peptide (named PAPep) derived from C-type lectin-like domain (CTLD) of human PAP with potent anti-inflammatory activity using both in vivo and in vitro assays. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the anti-inflammatory effect of PAPep on endotoxin-induced uveitis (EIU) in rats and demonstrated that intravitreal pretreatment of PAPep concentration-dependently attenuated clinical manifestation of EIU rats, reduced protein leakage and cell infiltration into the aqueous humor (AqH), suppressed tumor necrosis factor (TNF)-α, interleukin (IL)-6, intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein (MCP)-1 production in ocular tissues, and improved histopathologic manifestation of EIU. Furthermore, PAPep suppressed the LPS-induced mRNA expression of TNF-α and IL-6 in RAW 264.7 cells, inhibited protein expression of ICAM-1 in TNF-α-stimulated human umbilical vein endothelial cells (HUVECs) as well as U937 cells adhesion to HUVECs. Western blot analysis in ocular tissues and different cell lines revealed that the possible mechanism for this anti-inflammatory effect of PAPep may depend on its ability to inhibit the activation of NF-kB signaling pathway. CONCLUSIONS/SIGNIFICANCE: Our studies provide the first evidence that the sequence of PAPep is within the critically active region for the anti-inflammatory function of PAP and the peptide may be a promising candidate for the management of ocular inflammatory diseases.
first_indexed 2024-12-21T09:53:43Z
format Article
id doaj.art-6f6a2727789245d6a0ad18bd677f3010
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T09:53:43Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6f6a2727789245d6a0ad18bd677f30102022-12-21T19:08:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01612e2915510.1371/journal.pone.0029155A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.Xiaolu YangHuiyi JinKun LiuQing GuXun XuBACKGROUND: Pancreatitis-associated protein (PAP) is a pancreatic secretory protein belongs to the group VII of C-type lectin family. Emerging evidence suggests that PAP plays a protective effect in inflammatory diseases. In the present study, we newly identified a 16-amino-acid peptide (named PAPep) derived from C-type lectin-like domain (CTLD) of human PAP with potent anti-inflammatory activity using both in vivo and in vitro assays. METHODOLOGY/PRINCIPAL FINDINGS: We assessed the anti-inflammatory effect of PAPep on endotoxin-induced uveitis (EIU) in rats and demonstrated that intravitreal pretreatment of PAPep concentration-dependently attenuated clinical manifestation of EIU rats, reduced protein leakage and cell infiltration into the aqueous humor (AqH), suppressed tumor necrosis factor (TNF)-α, interleukin (IL)-6, intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein (MCP)-1 production in ocular tissues, and improved histopathologic manifestation of EIU. Furthermore, PAPep suppressed the LPS-induced mRNA expression of TNF-α and IL-6 in RAW 264.7 cells, inhibited protein expression of ICAM-1 in TNF-α-stimulated human umbilical vein endothelial cells (HUVECs) as well as U937 cells adhesion to HUVECs. Western blot analysis in ocular tissues and different cell lines revealed that the possible mechanism for this anti-inflammatory effect of PAPep may depend on its ability to inhibit the activation of NF-kB signaling pathway. CONCLUSIONS/SIGNIFICANCE: Our studies provide the first evidence that the sequence of PAPep is within the critically active region for the anti-inflammatory function of PAP and the peptide may be a promising candidate for the management of ocular inflammatory diseases.http://europepmc.org/articles/PMC3237597?pdf=render
spellingShingle Xiaolu Yang
Huiyi Jin
Kun Liu
Qing Gu
Xun Xu
A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
PLoS ONE
title A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
title_full A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
title_fullStr A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
title_full_unstemmed A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
title_short A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.
title_sort novel peptide derived from human pancreatitis associated protein inhibits inflammation in vivo and in vitro and blocks nf kappa b signaling pathway
url http://europepmc.org/articles/PMC3237597?pdf=render
work_keys_str_mv AT xiaoluyang anovelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT huiyijin anovelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT kunliu anovelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT qinggu anovelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT xunxu anovelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT xiaoluyang novelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT huiyijin novelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT kunliu novelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT qinggu novelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway
AT xunxu novelpeptidederivedfromhumanpancreatitisassociatedproteininhibitsinflammationinvivoandinvitroandblocksnfkappabsignalingpathway